Then, of course, there’s the M3 CSL, the best version of everyone’s favourite 3 Series. It was notable even in an ...

This video features a quarter-mile drag race between the BMW M3 CSL E46 and the VW Bora VR6. Both cars showcase their ...

The BMW M3 CSL E46 is a true driver's icon – lightweight, raw, and razor-sharp. Watch it unleash its full potential on the ...

Welcome back to Choices, where seemingly similar cars are pitted against one another in a battle for your affection.It’s like ...

CSL shares are in the green today. Despite short-term challenges and recent volatility, analysts see significant upside for CSL shares. Analysts like Macquarie and Bell Potter believe the shares are ...

This broker has reduced its view on this ASX 200 healthcare stock. Bell Potter reduced its 12-month price target for CSL Ltd (ASX: CSL). The broker noted modest FY26 revenue growth guidance and ...

Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

Defining the greatest sports cars ever made presents a deeper challenge, inviting a certain degree of madness. We think the ...

Sanofi’s $1.7 billion rare disease bet from last year has delivered a phase 2 win. In a midstage study, efdoralprin alfa beat the standard of care on primary and key secondary endpoints, positioning ...

The BMW F87 M2 CS is a collector's dream, with values rising fast. Don't miss your chance to own this rare beauty before ...

CSL has FDA approval for its new drug to prevent hereditary angioedema (HAE) attacks, Andembry, offering a new, first-in-class option for patients with the rare genetic disorder. Factor XIIa inhibitor ...

Domino’s Pizza, Premier Investments, CSL and GQG Partners are tempting buy-the-dip candidates, say fund managers. But just not yet. Health editor Michael Smith on CSL’s remarkable story, why investors ...